Capital International Inc’s Juno Therapeutics, Inc. JUNO Stock Holding History

Capital International Inc’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-64,450	Closed	-$2.95M	–	172
2017 Q4	$2.95M	Buy	64,450 +9,450	+17%	+$471K	0.44%	47
2017 Q3	$2.47M	Buy	+55,000	New	+$1.88M	0.36%	66

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Capital International Inc's JUNO Position: Q1 2018 in Review

Capital International Inc sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 64,450 shares — an estimated $2.95M sold.

Capital International Inc first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $2.95M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Capital International Inc reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Capital International Inc sold 64,450 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $2.95M.
Capital International Inc first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
Capital International Inc's Juno Therapeutics, Inc. position peaked at $2.95M in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Capital International Inc's 13F filing for Q1 2018, filed 15 May 2018.